Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninlaro Combinations in Elderly Multiple Myeloma
NCT02586038Phase 2Completed
- Start
- Oct 2015
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM). Started Oct 2015; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02586038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586038.